Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

T2 Biosystems, Inc. (TTOO) had Revenue of $7.19M for the most recently reported fiscal year, ending 2023-12-31.

Quarterly Annual

Figures for fiscal year ending 2023-12-31

Income Statement Financials
Revenue	$7.19M
Net Income	$-50.08M
Cost of Goods Sold	$15.36M
Gross Profit	$-8.17M
Operating Expenses	$56.86M
Operating Income	$-49.66M
Non-Operating Income/Expense	$-0.41M
Pre-Tax Income	$-50.08M
Normalized Pre-Tax Income	$-50.08M
Income after Taxes	$-50.08M
Income from Continuous Operations	$-50.08M
Consolidated Net Income/Loss	$-50.08M
Normalized Income after Taxes	$-50.08M
EBIT	$-49.66M
EBITDA	$-48.80M
Weighted-Average Shares Outstanding (Basic)	2.61M
Weighted-Average Shares Outstanding (Diluted)	2.61M
Earnings per Share (EPS) (Basic)	$-19.19
Earnings per Share (EPS) (Diluted)	$-19.19
Balance Sheet Financials
Current Assets	$25.19M
Property, Plant, and Equipment	$1.66M
Long-Term Assets	$9.61M
Total Assets	$34.80M
Current Liabilities	$56.15M
Long-Term Debt	--
Long-Term Liabilities	$6.68M
Total Liabilities	$62.83M
Common Equity	$-28.04M
Tangible Shareholders Equity	$-28.04M
Shareholders Equity	$-28.04M
Common Shares Outstanding	4.06M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-48.14M
Cash Flow from Investing Activities	$-0.19M
Cash Flow from Financial Activities	$52.69M
Beginning Cash	$11.88M
End Cash	$16.24M
Increase/Decrease in Cash	$4.36M
Stock-Based Compensation	$4.35M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	0.45
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	--
Debt to Equity Ratio	-1.47
Gross Margin	-113.58%
Operating Margin	-690.45%
EBIT Margin	-690.45%
EBITDA Margin	-678.51%
Pre-Tax Profit Margin	-696.19%
Profit Margin	-696.19%
Free Cash Flow	$-48.33M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.21
Inventory Turnover	3.19
Receiveable Turnover	5.07
Days Sales in Receivables	72.06
Return on Equity	178.62%
Return on Tangible Equity	178.62%
Return on Assets	-143.91%
Return on Investments	178.62%
Book Value Per Share	$-6.91
Free Cash Flow per Share	$-18.52
Operating Cash Flow per Share	$-18.44

Data from Zacks Investment Research, Inc.